Verification of Compendial Methods

Size: px
Start display at page:

Download "Verification of Compendial Methods"

Transcription

1 Verification of Compendial Methods ภญ.ดร ดร.ส ภาณ ดวงธ รปร ชา ส าน กยาและว ตถ เสพต ด กรมว ทยาศาสตร การแพทย 7 ม ถ นายน

2 Scopes : Overview Asean Analytical Validation Guidelines Verification of Compendial Methods EDQM AOAC USP ACTD BDN? 2

3 From ASEAN Analytical Validation Guidelines Type of Analytical Procedure Identification Testing for Impurities Assay Performance Characteristic Quantitative Limit test dissolution content/potency Accuracy Precision Repeatability Interm.Precision LOD LOQ Linearity Range 3

4 : The ability to measure accurately and specificity the analyte in the presence of components that may be expected to be present in the matrix The degree of interference : Active ingredients Excipients Impurities Degradation Products etc 4

5 : Identification Tests Demonstrate ability to select between compounds of closely related structure confirm positive and negative results Assay Demonstrate that the results are unaffected by spiked impurities or excipients Impurities Spike the drug product/substance with impurities and demonstrate appropriate accuracy and precision 5

6 : Impurities are available Demonstrate that the assay is unaffected by the present of spiked material (impurities and/or excipients) Impurities are not available Compare test results to a second wellcharacterized procedure For assay : compare the two result For Impurity Tests : compare purity profiles Peak Purity Test (e.g. PDA, MS) 6

7 Linearity: The ability of the method to elicit test results that are directly proportational to concentration within a given range Range: Interval between upper and lower levels of analyte demonstrated by the method Precision and accuracy expressed in the same units as the test results 7

8 Evaluation of Linearity Established across the range of the method Dilutions Separate weighings Evaluate by appropriate statistical methods (e.g.regression) include correlation coefficient, yintercept, slope, plot Minimum 5 concentrations 8

9 Determination of appropriate range Minimum specified range : assay : 80120% Impurity test : from QL to 120% spec Content unformity : 70130% test conc Dissolution testing : / 20% over specified range 9

10 Precision: The measure of the degree of agreement among test results when the method is applied repeatedly to multiple samplings of a homogeneous sample Expressed as %RSD for a statiscally significant number of samples 10

11 Precision: should be performed at 3 levels Repeatability Intermediate Precision Reproducibility 11

12 Precision: Repeatability Same operating conditions, short time interval Min of 9 determinations covering specified range of procedure (3 levels, 3 reps each) Min of 6 determinations at 100% test conc Intermediate Precision Withinlab variations Different days, analysts, equipment Reproducibility Precision between labs Collaborative studies 12

13 Accuracy: The closeness of test results to the true value obtained by the method established across the range 13

14 Accuracy: Drug Substance Analysis of reference material Compare results to a second, wellcharacterized method Drug Product Analysis of synthetic mixtures spiked with known quantities of components Compare results to a second, wellcharacterized method Determined concurrently with precision, linearlity and specificity 14

15 Accuracy: Impurities (Quantitation( Quantitation) Analysis of sample (Drug substances/drug product) spiked with known amounts of impurities Recommended Data Min of 9 determinations over a min of 3 conc levels covering the specified range (e.g. 3 conc/3 replicates each) Report as % recovery of known, added amount, or difference between the mean and true value, with confidence intervals 15

16 Detection Limit (LOD): Lowest concentration of analyte in a sample that can be detected (not necessarily quantitated) Limit test : above or below a certain level Expressed as concentration (%, ppb) Almost necessary not determine actual detection limit 16

17 Detection Limit (LOD): Visual (Noninstrumental methods) Signal to noise ratio (3:1 or 2:1 generally accepted) Detection limit may be based on the standard deviation of the response and slope: DL = (3.3)STD/S STD = standard deviation of the response S = slope of the calibration curve 17

18 Quantitation Limit (LOQ): Lowest concentration of analyte in a sample that can be determined with acceptable precision and accuracy under stated operational conditions Expressed as concentration of analyte accuracy precision 18

19 Quantitation Limit (LOQ): Visual (Noninstrumental methods) Signal to noise ratio (10:1 is typical) Quantitation limit may be based on the standard deviation of the response and slope: QL = (10)STD/S STD = standard deviation of the response S = slope of the calibration curve Both DL and QL are validated by analyzing a suitable number of samples. Method should be documented. 19

20 Verification of Compendial Methods EDQM AOAC USP ACTD 20

21 From EDQM : 1. Transfer of a Method A verification of suitability under conditions of use (=method transfer check) has to be done 1.1 Pharmacopoeial (compendial) method Active substance Identification: no formal validation required Testing for Impurities: no formal validation required Assay: no formal validation required 21

22 From EDQM : 1.1 Pharmacopoeial (compendial) method Medicinal product Identification: no formal validation required Testing for Impurities: specificity: no interference from excipients reporting threshold (at least the quant. limit) Assay: specificity accuracy: mainly recovery, min 1 det. precision (repeatability): around the target test conc. (min 2 independent det.) linearity at three measuring points in the range around the target value. 22

23 From AOAC : How to meet ISO requirements for Method Verification Activities needed for method verification are a subset of those for validation. 23

24 From AOAC : Performance Characteristics Included in a Validation Performance Characteristic Identification 1 Analyte at low conc quantitative 2 Analyte at low conc Limit test 3 Analyte at high conc quantitative 4 Analyte at high conc Limit test 5 Quanlitative 6 Accuracy No No No Precision No No No LOD No /No No No LOQ No No /No No No Ruggedness No No No No Linearity/ Range No No No No 24

25 From AOAC : How to meet ISO requirements for Method Verification Category1 : Confirmation of identity A method that ensures a material is what it purports to be or confirms the detection of the target analyte 25

26 Category1 : Identification Performance Characteristic Verification No If the lab s samples are identical to those in the standard method and if and differences in instrumentation do not impact specificity if the lab s sample differ from those in the standard method if differences between instruments could affect specificity Verification Activities NA Same as those required for validation The activity need only deal with the unique aspect s of the lab s samples or instrumentation 26

27 From AOAC : How to meet ISO requirements for Method Verification Category2 : Analyte at Low Concentration, Quantitative 27

28 Category2:Analyte at Low Concentration, Quantitative Performance Characteristic 1. Accuracy Verification Verification Activities If the concentration range for which the method is validated is narrow (<1 order of magnitude), analyze one reference material/standard/spike at one concentration level. Otherwise, demonstrate accuracy at each concentration level (low, middle, high) by anlyzing one reference material/standard/spike at each level. 28

29 Category2:Analyte at Low Concentration, Quantitative Performance Characteristic 2. Precision Verification Verification Activities Perform the repeatability test once. If the method covers a concentration range>1 order of magnitude, then the repeatability test must include low, middle and high concentrations. 29

30 Category2:Analyte at Low Concentration, Quantitative Performance Characteristic 3. Verification No/ Verification Activities 4. LOD Run a sample close to LOD 5. LOQ Run a sample close to LOQ 30

31 From AOAC : How to meet ISO requirements for Method Verification Category3 : Analyte is present above or below a specified, low concentration (Limit Test) 31

32 Category3 : Limit Test Performance Characteristic 1. Verification No/ Verification Activities 2. LOD Run a sample close to LOD 3. LOQ Run a sample close to LOQ 32

33 From AOAC : How to meet ISO requirements for Method Verification Category4 : Quantifying an analyte at high concentration 33

34 Category4 : Assay Performance Characteristic 1. Accuracy Verification Verification Activities If the concentration range for which the method is validated is narrow (<1 order of magnitude), analyze one reference material/standard/ spike at one concentration level. Otherwise, demonstrate accuracy at each concentration level (low, middle, high) by anlyzing one reference material/standard/spike at each level. 34

35 Category4 : Assay Performance Characteristic 2. Precision 3. Verification No/ Verification Activities Perform the repeatability test once. If the method covers a concentration range>1 order of magnitude, then the repeatability test must include low, middle and high concentrations. 35

36 From USP : Verification of Compendial Procedures <1226> 36

37 USP: Validation of Compendial Procedures <1225> Category II Performance Characteristic Category I (Assay) (Impurities) Quantitative Limit test Category III (dissolution) Category IV (Identification) Accuracy Precision LOD LOQ Linearity Range 37

38 Verification of Compendial Procedures<1226> Verification of Compendial Procedures. The purpose of this new general information chapter is to provide guidelines for verifying the suitability of a compendial procedure under actual conditions of use,, as stated in 21 CFR (a)(2). Because it is not necessary for users of compendial procedures to perform a complete validation, but rather, to confirm that the procedure works for their drug substance, excipient, or dosage form,, verification can be accomplished by assessing a subset of validation characteristics. This new chapter is considered an extension of the general information chapter Validation of Compendial Methods <1225>, and both chapters use similar terminology. Interested parties are encouraged to submit comments by July 15,

39 Verification of Compendial Procedures<1226> verifying the suitability of a compendial procedure under actual conditions of use But No Guidelines 39

40 Data Elements for Verification of Drug Substances and and Excipients* Technique Category (assay) Category II (impurities) Category III (dissolution) Category IV (identification) Quantitative Limit test HPLC/GC Precision Precision LOQ LOD Spectro photometric/ colorimetric Precision Precision LOQ LOD Titrimetric Precision Precision TLC LOQ LOD Gel Electro Phoresis LOQ LOD * Not official 40

41 Data Elements for Verification of Dosage Forms Technique Category I (assay) Category II (impurities) Category III (dissolution) Category IV (identification) Quantitative Limit test HPLC/GC Precision Linearity Range Precision LOQ LOD Precision Spectro photometric/ colorimetric Precision Linearity Range Precision LOQ LOD Precision Titrimetric Precision Linearity Range TLC Gel Electro phoresis * Not official Precision LOQ LOQ LOD LOD 41

42 Category I: Analytical procedures for quantitation of major components of drug substances or active ingredients (including preservatives) in finished dosage forms. Category II: Analytical procedures for determination of impurities in drug substances or degradation compounds in finished pharmaceutical products. These procedures include quantitative assays and limit tests. Category III: Analytical procedures for determination of performance characteristics (e.g., dissolution, drug release). Category IV: Identification procedures. 42

43 From ACTD P5 : Control of Finished Product 5.3 Validation of Analytical Procedure Verification of compendial method applicability Accuracy Precision 43

44 Comparison : Assay USP Precision Linearity Range EDQM Precision Linearity Accuracy AOAC Precision Accuracy 44

45 Recommendation (BDN): For Assay: Precision at 100 % (6 det.) Accuracy at 100% (3 det.) Linearity (5 points) 45

46 Comparison : Impurity (Quantitative) USP Precision LOQ EDQM LOQ AOAC Precision LOQ, LOD Accuracy 46

47 Recommendation (BDN): For Impurity (Quantitative) : LOQ Precision (6 det.) Accuracy (3 det.) 47

48 Comparison : Impurity (Limit tests) USP LOD EDQM LOQ (LOD?) AOAC LOQ, LOD 48

49 Recommendation (BDN): For Impurity (Limit tests) : LOD 49

50 Comparison : Identification USP EDQM No formal validation required AOAC 50

51 Verification documentation : The verification exercise must be planned, approved, and documented and a final report kept on file to demonstrate the lab can perform the method adequately. Verification documentation should be created that: Described the procedure to be verified Details the analytical performance characteristics to be evaluated Established acceptance criteria used to determine that the procedure perform suitably Justifies deviations from reference method 51

52 Thank You for Your Attention 52

á1225ñ VALIDATION OF COMPENDIAL PROCEDURES

á1225ñ VALIDATION OF COMPENDIAL PROCEDURES 1640 á1224ñ Transfer of Analytical Procedures / General Information USP 39 THE ANALYTICAL PROCEDURE The procedure should be written with sufficient detail and explicit instructions, so that a trained analyst

More information

VALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY *)

VALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY *) VALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY *) Guideline Title Validation of Analytical Procedures: Methodology Legislative basis Directive 75/318/EEC as amended Date of first adoption December 1996

More information

VICH Topic GL2 (Validation: Methodology) GUIDELINE ON VALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY

VICH Topic GL2 (Validation: Methodology) GUIDELINE ON VALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit CVMP/VICH/591/98-FINAL London, 10 December 1998 VICH Topic GL2 (Validation: Methodology) Step 7 Consensus

More information

Validation of Analytical Methods used for the Characterization, Physicochemical and Functional Analysis and of Biopharmaceuticals.

Validation of Analytical Methods used for the Characterization, Physicochemical and Functional Analysis and of Biopharmaceuticals. Validation of Analytical Methods used for the Characterization, Physicochemical and Functional Analysis and of Biopharmaceuticals. 1 Analytical Method Validation: 1..1 Philosophy: Method validation is

More information

TEMPLATE FOR AN EXAMPLE METHODS VALIDATION STANDARD OPERATING PROCEDURE (SOP)

TEMPLATE FOR AN EXAMPLE METHODS VALIDATION STANDARD OPERATING PROCEDURE (SOP) APPENDIX II TEMPLATE FOR AN EXAMPLE METHODS VALIDATION STANDARD OPERATING PROCEDURE (SOP) SOP EXAMPLE TEMPLATE 1. PURPOSE 1.1 This procedure is intended to provide general guidelines for the validation

More information

ICH Q2(R1) A Primer. cgmp. GxP PIC/S SOP ISO QA/QC LOD/LOQ. Validation of Analytical Methods API EP FDA OECD GCP

ICH Q2(R1) A Primer. cgmp. GxP PIC/S SOP ISO QA/QC LOD/LOQ. Validation of Analytical Methods API EP FDA OECD GCP USP ICH Q2(R1) A Primer GxP cgmp PIC/S SOP ISO 17025 QA/QC LOD/LOQ API EP Validation of Analytical Methods FDA OECD GCP Validation of Analytical Methods Ludwig Huber Contents Preface...............................................

More information

Understanding the Characteristics and Establishing Acceptance Criteria for Analytical Methods Validation

Understanding the Characteristics and Establishing Acceptance Criteria for Analytical Methods Validation Understanding the Characteristics and Establishing Acceptance Criteria for Analytical Methods Validation Ying Verdi IVT LAB WEEK EUROPE June 2017 Partners in Health Since 1919 Regulatory View of Method

More information

GUIDANCE NOTES ON ANALYTICAL METHOD VALIDATION

GUIDANCE NOTES ON ANALYTICAL METHOD VALIDATION ON ANALYTICAL METHOD VALIDATION HSA September 2004 Reproduction prohibited for commercial purposes. Reproduction for internal use is authorised, provided the source is acknowledged. MQA Dir: DISK1\GUIDE-MQA-012A-004.doc

More information

Analytical Procedures and Methods Validation for Drugs and Biologics

Analytical Procedures and Methods Validation for Drugs and Biologics Final Guidance for Industry Analytical Procedures and Methods Validation for Drugs and Biologics Analytical procedures and Method Validation June 21, 2016 Lokesh Bhattacharyya Chief, LACBRP/DBSQC OCBQ/CBER/FDA

More information

Impurity Control in the European Pharmacopoeia

Impurity Control in the European Pharmacopoeia Impurity Control in the European Pharmacopoeia Training Session Zagreb, Croatia, 24-25 May, 2018 Dr Ulrich Rose Head of Division European Pharmacopoeia Department, EDQM Agenda Which impurities are controlled?

More information

CRITERIA FOR VALIDATION OF METHODS USED BY CHEMICAL LABORATORIES AND RELATED INDUSTRIES

CRITERIA FOR VALIDATION OF METHODS USED BY CHEMICAL LABORATORIES AND RELATED INDUSTRIES Document No: SADCAS TR 17 Issue No: 1 CRITERIA FOR VALIDATION OF METHODS USED BY CHEMICAL LABORATORIES AND RELATED INDUSTRIES Prepared by: SADCAS Advisory Committee TLAP Approved by: SADCAS CEO Approval

More information

Perspectives on Method Validation: Importance of Adequate Method Validation

Perspectives on Method Validation: Importance of Adequate Method Validation Perspectives on Method Validation: Importance of Adequate Method Validation Heather Bridwell, Vikas Dhingra, Daniel Peckman, Jennifer Roark and Thomas Lehman The appropriate validation of analytical methods

More information

Method Development and Validation for Online UV-Dissolution Methods Using Fiber-Optic Technology

Method Development and Validation for Online UV-Dissolution Methods Using Fiber-Optic Technology Technical Overview Method Development and Validation for Online UV-Dissolution Methods Using Fiber-Optic Technology Introduction Online fiber-optic and multicell UV-dissolution systems have become increasingly

More information

Phase Appropriate Method Validation

Phase Appropriate Method Validation Phase Appropriate Method Validation Aryo Nikopour Irvine, California January 12, 2017 The Southern California Pharmaceutical Discussion Group (SCPDG) of AAPS OUTLINE What is Validation Guidelines Method

More information

Thank You to United States Pharmacopeia for Their Sponsorship and Assistance

Thank You to United States Pharmacopeia for Their Sponsorship and Assistance Use of Measurement Uncertainty in Testing a Drug Substance M.L. Jane Weitzel Quality Analysis Consultants mljweitzel@msn.com Eurachem/CITAC Workshop June 2011 Thank You to United States Pharmacopeia for

More information

10. Validated Normal Phase HPLC Method for the Determination. Fulvestrant is primarily used in the treatment of hormone receptor

10. Validated Normal Phase HPLC Method for the Determination. Fulvestrant is primarily used in the treatment of hormone receptor 229 10. Validated Normal Phase HPLC Method for the Determination of Fulvestrant in Pharmaceutical Dosage Forms 10.1 Introduction Fulvestrant is primarily used in the treatment of hormone receptor positive

More information

Validation/Verification of Test Methods An FDA Perspective. Laure H. Kairawicz, Ph.D. Senior Scientist Expert Witness

Validation/Verification of Test Methods An FDA Perspective. Laure H. Kairawicz, Ph.D. Senior Scientist Expert Witness Validation/Verification of Test Methods An FDA Perspective Laure H. Kairawicz, Ph.D. Senior Scientist Expert Witness FD & C Act Overview Definition of drugs What cgmps are Finished Pharmaceuticals cgmp

More information

A2LA. R231 Specific Requirements: Threat Agent Testing Laboratory Accreditation Program. December 6, 2017

A2LA. R231 Specific Requirements: Threat Agent Testing Laboratory Accreditation Program. December 6, 2017 Laboratory Page 1 of 17 Laboratory December 6, 2017 2017 by A2LA All rights reserved. No part of this document may be reproduced in any form or by any means without the prior written permission of A2LA.

More information

3. Equipment Cleaning Validation for Active Pharmaceutical Ingredients (APIs) 8. Process Validation for Active Pharmaceutical Ingredients (API)

3. Equipment Cleaning Validation for Active Pharmaceutical Ingredients (APIs) 8. Process Validation for Active Pharmaceutical Ingredients (API) Title: Good Working Practice Validation Requirements Practice Number: 06 Prepared by: Date: Supersedes: Checked by: Date: Date Issued: Approved by: Date: Review Date: Topics: 1. Biological Test Methods

More information

Revision of 30 April 2013 draft, 4 November 2013

Revision of 30 April 2013 draft, 4 November 2013 GUIDANCE DOCUMENT FOR SINGLE LABORATORY VALIDATION OF QUANTITATIVE ANALYTICAL METHODS USED IN SUPPORT OF PRE- AND POST-REGISTRATION DATA REQUIREMENTS FOR PLANT PROTECTION AND BIOCIDAL PRODUCTS INTRODUCTION

More information

Validation & Transfer of Methods for

Validation & Transfer of Methods for Validation & Transfer of Methods for Course option 1: Pharmaceutical Analysis, or Course option 2: Biopharmaceutical Analysis TRAINING COURSE This course will provide you with the requisite scientific

More information

Fusion Analytical Method Validation

Fusion Analytical Method Validation Fusion QbD Software System Fusion Analytical Method Validation The Only Software That Has It All! 100% aligned with FDA/ICH Quality by Design (QbD) guidances! Can be used for LC and Non-LC methods (e.g.

More information

Review on Analytical Method Development and Validation.

Review on Analytical Method Development and Validation. Research and Reviews: Journal of Pharmaceutical Analysis Review on Analytical Method Development and Validation. Rajendra Patil 1*, Tushar Deshmukh 1, Vijay Patil 1, and Kishanchand Khandelwal 2.. 1 TVES

More information

9/2/2014. USP Monograph Modernization. Todays topics. USP basic. Todays topics. - USP basic. - USP publications. - USP monograph modernization

9/2/2014. USP Monograph Modernization. Todays topics. USP basic. Todays topics. - USP basic. - USP publications. - USP monograph modernization USP Monograph Modernization Procedure Review and Development Donald Min 2 USP basic Since USP's founding in 1820, our operations have grown exponentially: from 11 volunteers collaborating from their respective

More information

TECHNICAL GUIDANCE FOR THE VALIDATION OF METHODS USED BY CHEMICAL LABORATORIES IN THE FOOD, WATER AND RELATED INDUSTRIES

TECHNICAL GUIDANCE FOR THE VALIDATION OF METHODS USED BY CHEMICAL LABORATORIES IN THE FOOD, WATER AND RELATED INDUSTRIES TECHNICAL GUIDANCE FOR THE VALIDATION OF METHODS USED BY CHEMICAL LABORATORIES IN THE FOOD, WATER AND RELATED INDUSTRIES Approved By: Chief Executive Officer: Ron Josias Senior Manager: Christinah Leballo

More information

Verification of Method XXXXXX

Verification of Method XXXXXX Reviewed By: Date: Technical Supervisor Reviewed By: Date: General Supervisor Reviewed By: Date: Quality Assurance Coordinator Approved By: Date: Director Page 1 of 11 Table of Contents Purpose and Principle:...

More information

Bioanalytical method validation: An updated review

Bioanalytical method validation: An updated review Review Article www.phmethods.org Bioanalytical method validation: An updated review Abstract The development of sound bioanalytical method(s) is of paramount importance during the process of drug discovery

More information

Regulatory Expectations for Method Transfers: Health Canada's Perspective CMC Strategy Forum Methods on the move January 23, 2017

Regulatory Expectations for Method Transfers: Health Canada's Perspective CMC Strategy Forum Methods on the move January 23, 2017 Regulatory Expectations for Method Transfers: Health Canada's Perspective CMC Strategy Forum Methods on the move January 23, 2017 Hugo Hamel, Senior Biologist/Evaluator, BGTD Overview of the Post-NOC Changes

More information

Application note. Guideline for validation of analytical methods using Cedex Bio, Cedex Bio HT, and Cedex HiRes Analyzers.

Application note. Guideline for validation of analytical methods using Cedex Bio, Cedex Bio HT, and Cedex HiRes Analyzers. Application note Guideline for validation of analytical methods using Cedex Bio, Cedex Bio HT, and Cedex HiRes Analyzers April 216 Doerthe Druhmann, Sabrina Schuette, Dr. Dirk Ponsel Pharma Biotech, Penzberg,

More information

Analytical Methods Development and Validation

Analytical Methods Development and Validation Understanding and Implementing Efficient Analytical Methods Development and Validation Jay Breaux, Kevin Jones, and Pierre Boulas Analytical methods development and validation play important roles in the

More information

A Simple Rapid and Sensitive Method Development for Quantification of Quetiapine Fumarate in Bulk and Dosage Forms Using RP-HPLC

A Simple Rapid and Sensitive Method Development for Quantification of Quetiapine Fumarate in Bulk and Dosage Forms Using RP-HPLC Human Journals Research Article February 2018 Vol.:11, Issue:3 All rights are reserved by Priyanka Teepoju et al. A Simple Rapid and Sensitive Method Development for Quantification of Quetiapine Fumarate

More information

Agreed by VICH Steering Committee January Adoption by CVMP 12 February Date for coming into effect January 2016

Agreed by VICH Steering Committee January Adoption by CVMP 12 February Date for coming into effect January 2016 12 February 2015 EMA/CVMP/VICH/463202/2009 Committee for Medicinal Products for Veterinary Use (CVMP) VICH topic GL49: Studies to evaluate the metabolism and residues kinetics of veterinary drugs in human

More information

Click to edit Master text styles

Click to edit Master text styles Quantitative Second estimation level of Anti-degradants in tyre components Presented by Tirthankar Bhandary 1 Degradation of polymer BACKGROUND Reaction of anti-degradant Possibility of resonance of radical

More information

Technical requirements to Good Manufacturing Practice in metered dose inhalers production and development (2. part) Extractable - Leachable

Technical requirements to Good Manufacturing Practice in metered dose inhalers production and development (2. part) Extractable - Leachable Technical requirements to Good Manufacturing Practice in metered dose inhalers production and development (2. part) Extractable - Leachable Dr. Gyula Körtvélyessy UNIDO Honorary Secretary General of the

More information

1225 VALIDATION OF lytical performance characteristics that should be considered COMPENDIAL PROCEDURES

1225 VALIDATION OF lytical performance characteristics that should be considered COMPENDIAL PROCEDURES USP 36 General Information / 1225 Validation of Compendial Procedures 1 formance characteristics of the procedure meet the requirements for the intended analytical applications. Typical ana- 1225 VALIDATION

More information

METHOD VALIDATION TECHNIQUES PREPARED FOR ENAO ASSESSOR CALIBRATION COURSE OCTOBER/NOVEMBER 2012

METHOD VALIDATION TECHNIQUES PREPARED FOR ENAO ASSESSOR CALIBRATION COURSE OCTOBER/NOVEMBER 2012 METHOD VALIDATION PREPARED FOR ENAO ASSESSOR CALIBRATION COURSE TECHNIQUES OCTOBER/NOVEMBER 2012 Prepared by for ENAO Assessor Calibration B SCOPE Introduction House Rules Central Tendency Statistics Population

More information

VICH Topic GL49. at step 4 GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS USED IN RESIDUE DEPLETION STUDIES

VICH Topic GL49. at step 4 GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS USED IN RESIDUE DEPLETION STUDIES European Medicines Agency Veterinary Medicines and Inspections London, 14 December 2009 Doc. Ref. EMEA/CVMP/VICH/463202/2009-CONSULTATION VICH Topic GL49 at step 4 GUIDELINES FOR THE VALIDATION OF ANALYTICAL

More information

European Pharmacopoeia Reference Standards A Lodi, Head of the Laboratory Department, EDQM, Council of Europe

European Pharmacopoeia Reference Standards A Lodi, Head of the Laboratory Department, EDQM, Council of Europe European Pharmacopoeia Reference Standards A Lodi, Head of the Laboratory Department, EDQM, Council of Europe Content Ph. Eur. Reference Standards General notices, terms and definitions Key attributes

More information

We are IntechOpen, the first native scientific publisher of Open Access books. International authors and editors. Our authors are among the TOP 1%

We are IntechOpen, the first native scientific publisher of Open Access books. International authors and editors. Our authors are among the TOP 1% We are IntechOpen, the first native scientific publisher of Open Access books 3,350 108,000 1.7 M Open access books available International authors and editors Downloads Our authors are among the 151 Countries

More information

Functionality. Normal Operation

Functionality. Normal Operation Application Note Automating EPA Method 200.8 using the SDXHPLD High Performance Liquid Dilution System Jim Maximovich, Teledyne CETAC Technologies, Omaha, NE, USA, Jim.Maximovich@Teledyne.com The SDX HPLD

More information

Chemical Aspects of Stability Evaluation

Chemical Aspects of Stability Evaluation Chemical Aspects of Stability Evaluation 8 steps to generating stability data which speaks for itself Alan Doughty Chief Chemist Pty Ltd Aim of a stability trial Obtain data which allows a definitive conclusion

More information

An Alternative Approach to Quantitative Methods: Limit test for Analysis of Deeming Analytes in Electronic Cigarettes

An Alternative Approach to Quantitative Methods: Limit test for Analysis of Deeming Analytes in Electronic Cigarettes An Alternative Approach to Quantitative Methods: Limit test for Analysis of Deeming Analytes in Electronic Cigarettes Carl Adams, Salem Chouchane and Darius Grissom www.eurofinslancasterlabs.com Questions

More information

Lifecycle Management Concepts to analytical Procedures: A compendial perspective. Horacio Pappa, Ph.D. Director - General Chapters U.S.

Lifecycle Management Concepts to analytical Procedures: A compendial perspective. Horacio Pappa, Ph.D. Director - General Chapters U.S. Lifecycle Management Concepts to analytical Procedures: A compendial perspective Horacio Pappa, Ph.D. Director - General Chapters U.S. Pharmacopeia USP Definitions Validation of Compendial Procedures

More information

Analytical Method Transfer Program. Richard B. Nguyen. Associate Scientific Liaison, Chemical Medicines, USP

Analytical Method Transfer Program. Richard B. Nguyen. Associate Scientific Liaison, Chemical Medicines, USP Analytical Method Transfer Program Richard B. Nguyen. Associate Scientific Liaison, Chemical Medicines, USP Outline Requirements for an AMT Program Develop Your AMT Program Qualify Your AMT Program On-going

More information

BIOEQUIVALENCE TRIAL INFORMATION FORM (Medicines and Allied Substances Act [No. 3] of 2013 Part V Section 39)

BIOEQUIVALENCE TRIAL INFORMATION FORM (Medicines and Allied Substances Act [No. 3] of 2013 Part V Section 39) ZAMRA BTIF BIOEQUIVALENCE TRIAL INFORMATION FORM (Medicines and Allied Substances Act [No. 3] of 2013 Part V Section 39) The Guidelines on Bioequivalence Studies to be consulted in completing this form.

More information

Understanding and accounting for product

Understanding and accounting for product Understanding and Modeling Product and Process Variation Variation understanding and modeling is a core component of modern drug development. Understanding and accounting for product and process variation

More information

Additional guidance on: TNsG on Data Requirements, Part A, Chapter 2, Point 4. Analytical Methods for Detection and Identification.

Additional guidance on: TNsG on Data Requirements, Part A, Chapter 2, Point 4. Analytical Methods for Detection and Identification. Additional guidance on: TNsG on Data Requirements, Part A, Chapter 2, Point 4 Analytical Methods for Detection and Identification and Part B, Chapter 2, Point 4 Methods of Identification and Analysis These

More information

Development and validation of stability indicating RP-HPLC method for the estimation of Daclatasvir in bulk and formulation

Development and validation of stability indicating RP-HPLC method for the estimation of Daclatasvir in bulk and formulation Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2016, 8 (15):107-113 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

Automating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper

Automating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper Automating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper Varian, Inc. 2700 Mitchell Drive Walnut Creek, California 94598, USA www.varianinc.com Introduction Chromatographic

More information

Proposed New USP General Chapter: The Analytical Procedure Lifecycle 1220

Proposed New USP General Chapter: The Analytical Procedure Lifecycle 1220 Page 1 of 9 STIMULI TO THE REVISION PROCESS Stimuli articles do not necessarily reflect the policies of the USPC or the USP Council of Experts Proposed New USP General Chapter: The Analytical Procedure

More information

Analytical Procedures and Methods Validation for Drugs and Biologics

Analytical Procedures and Methods Validation for Drugs and Biologics Analytical Procedures and Methods Validation for Drugs and Biologics Lucinda (Cindy) Buhse, Ph. D. Acting Director, Office of Testing and Research Office of Pharmaceutical Science CDER, FDA CHPA Quality

More information

Fusion Analytical Method Validation

Fusion Analytical Method Validation Fusion QbD Software Platform Fusion Analytical Method Validation The Only Software That Has It All! 100% aligned with FDA/ICH Quality by Design (QbD) guidances! Can be used for LC and Non-LC methods (e.g.

More information

DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ASSAY DETERMINATION OF ISOSULFAN BLUE BY LIQUID CHROMATOGRAPHY

DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ASSAY DETERMINATION OF ISOSULFAN BLUE BY LIQUID CHROMATOGRAPHY DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ASSAY DETERMINATION OF ISOSULFAN BLUE BY LIQUID CHROMATOGRAPHY KISHORKUMAR L.MULE 1 Department of Chemistry, Shri Jagdish Prasad Jhabarmal Tibrewala

More information

Automating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper

Automating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper Automating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper S-Matrix Corporation 1594 Myrtle Avenue Eureka, CA 95501, USA www.smatrix.com Introduction Chromatographic analytical

More information

General concepts in the Ph. Eur.: theory and rationale

General concepts in the Ph. Eur.: theory and rationale General concepts in the Ph. Eur.: theory and rationale General Notices, General Chapters and General Monographs Cathie Vielle Head of European Pharmacopoeia Department The structure of the Ph. Eur. 2 General

More information

CASE-STUDY- VALIDATION of PCR based methodology. Beata Surmacz-Cordle Senior Analytical Development Scientist

CASE-STUDY- VALIDATION of PCR based methodology. Beata Surmacz-Cordle Senior Analytical Development Scientist CASE-STUDY- VALIDATION of PCR based methodology Beata Surmacz-Cordle Senior Analytical Development Scientist UK RMP Pluripotent Stem Cell Platform Validation Workshop 2 nd June 2016 RT-qPCR assay for detection

More information

GOOD LABORATORY PRACTICE Agilent Cary 8454 UV-Visible Spectroscopy System

GOOD LABORATORY PRACTICE Agilent Cary 8454 UV-Visible Spectroscopy System GOOD LABORATORY PRACTICE Agilent Cary 8454 UV-Visible Spectroscopy System Introduction The objective of good laboratory practice (GLP) is to obtain accurate and precise results, using a measurement system

More information

STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS

STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS

More information

JAI RESEARCH FOUNDATION A Global Contract Research Organisation

JAI RESEARCH FOUNDATION A Global Contract Research Organisation JAI RESEARCH FOUNDATION A Global Contract Research Organisation METHOD FOR THE DETERMINATION OF MANCOZEB RESIDUES IN TEST MEDIA FOR ECOTOX STUDIES Author : S.Y. Pandey and P.K. Dubey Jai Research Foundation

More information

Medicines Control Authority Of Zimbabwe

Medicines Control Authority Of Zimbabwe Medicines Control Authority Of Zimbabwe BIOEQUIVALENCE APPLICATION FORM Form: EVF03 This application form is designed to facilitate information exchange between the Applicant and the MCAZ for bioequivalence

More information

Regulatory Perspective on Analytical Method Validation During Product Development

Regulatory Perspective on Analytical Method Validation During Product Development Regulatory Perspective on Analytical Method Validation During Product Development CASSS CMC Strategy Forum 2018 Jacek Cieslak CDER/OPQ/OBP FDA Disclaimer This presentation reflects the views of the author

More information

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 17 December 2003 CPMP/QWP/122/02, rev 1 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) GUIDELINE

More information

Analytical Method of Limit Test for Hexachlorobenzene. in Picloram TC and Method Validation Data*

Analytical Method of Limit Test for Hexachlorobenzene. in Picloram TC and Method Validation Data* Analytical Method of Limit Test for Hexachlorobenzene in Picloram TC and Method Validation Data* Test Method (ABCTM-2010-01-07) 1. Apparatus Electronic Balance GC/MS System with NCI Ultrasonic Water Bath

More information

RADIOPHARMACY GMP QC HPLC VALIDATION

RADIOPHARMACY GMP QC HPLC VALIDATION RADIOPHARMACY GMP QC HPLC VALIDATION AERTS JoëlPhD, PARIS-DIDEROT, ULG GIACOMELLI Fabrice PhD, ULG HUBERT Philippe PhD, ULG IANNIELLO Jimmy Pharm, ULG MARINI Roland PhD, ULG 17th symposium of the Belgian

More information

Analytical Validation within the Pharmaceutical Environment

Analytical Validation within the Pharmaceutical Environment 3 1 Analytical Validation within the Pharmaceutical Environment Joachim Ermer Validation is, of course, a basic requirement to ensure quality and reliability of the results for all analytical applications

More information

11 th INTERNATIONAL SYMPOSIUM ON PHARMACEUTICAL REFERENCE STANDARDS. Siriphorn Laomanacharoen 21 December 2012

11 th INTERNATIONAL SYMPOSIUM ON PHARMACEUTICAL REFERENCE STANDARDS. Siriphorn Laomanacharoen 21 December 2012 11 th INTERNATIONAL SYMPOSIUM ON PHARMACEUTICAL REFERENCE STANDARDS Siriphorn Laomanacharoen 21 December 2012 11 th INTERNATIONAL SYMPOSIUM ON PHARMACEUTICAL REFERENCE STANDARDS Organised by European Directorate

More information

BIOEQUIVALENCE TRIAL INFORMATION

BIOEQUIVALENCE TRIAL INFORMATION PRESENTATION OF BIOEQUIVALENCE TRIAL INFORMATION BIOEQUIVALENCE TRIAL INFORMATION GENERAL INSTRUCTIONS: Please review all the instructions thoroughly and carefully prior to completing the Bioequivalence

More information

Extending Beyond Use Dating for Compounded Preparations Webinar Q&A

Extending Beyond Use Dating for Compounded Preparations Webinar Q&A Stability Studies 1. If potency over time studies are not acceptable to extend BUD, then why is it offered? Potency point-in-time studies only indicate the potency of a compounded preparation at that specific

More information

Extending Beyond Use Dating for Compounded Preparations Webinar Q&A

Extending Beyond Use Dating for Compounded Preparations Webinar Q&A Stability Studies 1. If potency over time studies are not acceptable to extend BUD, then why is it offered? Potency point-in-time studies only indicate the potency of a compounded preparation at that specific

More information

Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services

Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services Disclosures I, Ross Caputo, declare no conflicts of interest, real or apparent, and

More information

validation report for TaqMan Roundup Ready Quantification Kit

validation report for TaqMan Roundup Ready Quantification Kit validation report for TaqMan Roundup Ready Quantification Kit Life Technologies offers a breadth of products DNA RNA protein cell culture instruments For Research Use Only. Not intended for any animal

More information

INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND LIFE SCIENCES

INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND LIFE SCIENCES B. Venkateswara Reddy et al IJRPLS, 2014, 2(2): 236-247 Review Article Available online at www.pharmaresearchlibrary.com/ijrpls ISSN: 2321-5038 INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND LIFE SCIENCES

More information

CLSI C60: Assay Validation & Post-Validation Monitoring

CLSI C60: Assay Validation & Post-Validation Monitoring CLSI C60: Assay Validation & Post-Validation Monitoring Ross J. Molinaro, MT(ASCP), PhD, DABCC, FACB Medical Director Core Laboratory, Emory University Hospital Midtown Emory Clinical Translational Research

More information

Validation of a concentration assay using Biacore C

Validation of a concentration assay using Biacore C GE Healthcare Application Note 48 Biacore systems Validation of a concentration assay using Biacore C Guideline for development of a GxP - compliant concentration assay Support for informed decision-making

More information

Correlation coefficient

Correlation coefficient Application Note The SDXHPLD High Performance Liquid Dilution System yields smaller %RSD, therefore it provides cost savings and more profitability when utilized with Precious Metals Extracts Jim Maximovich,

More information

Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH)

Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH) Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH) *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY!

More information

Available online at ScienceDirect. Procedia Engineering 132 (2015 )

Available online at  ScienceDirect. Procedia Engineering 132 (2015 ) Available online at www.sciencedirect.com ScienceDirect Procedia Engineering 132 (2015 ) 811 815 The Manufacturing Engineering Society International Conference, MESIC 2015 Metrological Regulations for

More information

Examples of regulatory expectations for analytical characterization and testing

Examples of regulatory expectations for analytical characterization and testing Examples of regulatory expectations for analytical characterization and testing AT Europe 2016, 18 March 2016 Vicki Venizelos Quality RA B.V. Leiden, the Netherlands Overview What are the regulatory expectations?

More information

Pharmacopoeial Reference Standards

Pharmacopoeial Reference Standards Pharmacopoeial Reference Standards Industry view point Antony Raj Gomes Head- Quality Management 1 Presentation Overview Indian Industry an update Available guidelines Industry practices Current challenges

More information

WHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products

WHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products WHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products 1. Introduction 1.1 Objectives of these guidelines 1.2 Scope of these guidelines 1.3 General principles

More information

API Stability Protocols and. Chris Byrne Tasmanian Alkaloids

API Stability Protocols and. Chris Byrne Tasmanian Alkaloids API Stability Protocols and Evaluations Chris Byrne Tasmanian Alkaloids API Stability Overview APIs = 100% pure Limited (if any) degradation No interactions with other agents in drug products Less likelihood

More information

EUROPEAN COMMISSION Directorate General Health and Consumer Protection. SANCO/3030/99 rev.4 11/07/00

EUROPEAN COMMISSION Directorate General Health and Consumer Protection. SANCO/3030/99 rev.4 11/07/00 EUROPEAN COMMISSION Directorate General Health and Consumer Protection SANCO/3030/99 rev.4 11/07/00 Technical Material and Preparations: Guidance for generating and reporting methods of analysis in support

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Bioanalytical Methods Validation for Human Studies DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft

More information

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

USP Chapter 823 USP 32 (old) vs. USP 35 (new) USP Chapter 823 USP 32 (old) vs. USP 35 (new) Sally W. Schwarz, MS, BCNP Research Associate Professor of Radiology Washington University School of Medicine St. Louis, MO Why USP Chapter ? FDA has

More information

OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT

OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT PA/PH/OMCL (13) 113 2R Evaluation and Reporting of Results Core document Full document title and reference Evaluation and Reporting of Results

More information

Validation of a Dual Wavelength Size Exclusion HPLC Method with Improved Sensitivity to Detect Aggregates of a Monoclonal Antibody Biotherapeutic

Validation of a Dual Wavelength Size Exclusion HPLC Method with Improved Sensitivity to Detect Aggregates of a Monoclonal Antibody Biotherapeutic Validation of a Dual Wavelength Size Exclusion HPLC Method with Improved Sensitivity to Detect Aggregates of a Monoclonal Antibody Biotherapeutic By J. Tompkins1, T. Spurgeon 1, R. Tobias 1, J. Anders1,

More information

GUIDELINE FOR THE STABILITY TESTING

GUIDELINE FOR THE STABILITY TESTING 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 GUIDELINE FOR THE STABILITY TESTING OF NON-PRESCRIPTION (OTC)

More information

LEGAL REQUIREMENTS FOR STABILITY

LEGAL REQUIREMENTS FOR STABILITY BY DR. A.V.PRABHU LEGAL REQUIREMENTS FOR STABILITY 21 CFR 211.166- STABILITY TESTING GMP To assess stability characteristics to determine storage conditions and expiration dates. Written stability program

More information

Lifecycle Management of Process Analytical Technology Procedures

Lifecycle Management of Process Analytical Technology Procedures Lifecycle Management of Process Analytical Technology Procedures IFPAC 2015 Marta Lichtig Senior Scientist in New Testing Technologies, ACS Member Contents General Comparison : PV guide to NIR model development

More information

Institute for Reference Materials and Measurements Community Reference Laboratory for Feed Additives

Institute for Reference Materials and Measurements Community Reference Laboratory for Feed Additives EUROPEAN COMMISSION JOINT RESEARCH CENTRE Institute for Reference Materials and Measurements Community Reference Laboratory for Feed Additives D08/FSQ/CVH/GS/D(2007) 18417 CRL Evaluation Report on the

More information

International Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: , ISSN(Online): Vol.10 No.6, pp , 2017

International Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: , ISSN(Online): Vol.10 No.6, pp , 2017 International Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: 0974-4290, ISSN(Online):2455-9555 Vol.10 No.6, pp 1073-1082, 2017 Cost Effective Stabilty Indicating Reverse Phase High Performance

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF DOXAZOSIN FOR THE PRESENCE OF DEGRADATION PRODUCTS AND RELATED

More information

THE DISSOLUTION PROCEDURE: DEVELOPMENT AND VALIDATION

THE DISSOLUTION PROCEDURE: DEVELOPMENT AND VALIDATION THE DISSOLUTION PROCEDURE: DEVELOPMENT AND VALIDATION Pharmacopeial Forum Vol. 31(5)(Sept.-Oct. 2005) By : Mr. Seubpong Kumpusiri Mrs. Patima Maneesatid 26 May 2006 THE DISSOLUTION PROCEDURE: DEVELOPMENT

More information

DECISION TREE #1: ESTABLISHING ACCEPTANCE CRITERION FOR A SPECIFIED IMPURITY IN A NEW DRUG SUBSTANCE

DECISION TREE #1: ESTABLISHING ACCEPTANCE CRITERION FOR A SPECIFIED IMPURITY IN A NEW DRUG SUBSTANCE DECISION TREE #1: ESTABLISHING ACCEPTANCE CRITERION FOR A SPECIFIED IMPURITY IN A NEW DRUG SUBSTANCE Determine impurity level in relevant batches 1 Determine mean + upper confidence limit for the impurity

More information

Validation of Thin Layer Chromatographic Procedures

Validation of Thin Layer Chromatographic Procedures Validation of Thin Layer Chromatographic Procedures International Symposium for High-Performance Thin-Layer Chromatography HPTLC 2011 July 7th, 2011, Basle Topics ICH Q2(R1) and nothing else? Other guidance

More information

Laboratory Developed Tests. William Castellani, MD Inter-regional Commissioner Clinical Pathologist, Penn State Hershey Medical Center

Laboratory Developed Tests. William Castellani, MD Inter-regional Commissioner Clinical Pathologist, Penn State Hershey Medical Center Laboratory Developed Tests William Castellani, MD Inter-regional Commissioner Clinical Pathologist, Penn State Hershey Medical Center Objectives Compare and contrast new test validation requirements for

More information

Draft regional guidelines on stability testing of active substances and pharmaceutical products

Draft regional guidelines on stability testing of active substances and pharmaceutical products Regional Committee for the EM/RC53/12 Eastern Mediterranean August 2006 Fifty-third Session Original: Arabic Agenda item 17 Draft regional guidelines on stability testing of active substances and pharmaceutical

More information

Pesticides: Method Validation and Quality Control

Pesticides: Method Validation and Quality Control The guidance in 10684/2009 is intended for laboratories control or in the monitoring of pesticide residues in food involved in official and feed in the European Union. The document describes the method

More information

STIMULI TO THE REVISION PROCESS. Bioassay Glossary

STIMULI TO THE REVISION PROCESS. Bioassay Glossary Vol. 32(4) [July Aug. 2006] of the USPC or the USP Council of Experts 1359 Bioassay Glossary Robert Singer, PDL Biopharma; David M. Lansky, Lansky Consulting; and Walter W. Hauck, Thomas Jefferson University

More information

Automating EPA 6020 Compliant Analysis with the Agilent 7900 ICP-MS and ESI prepfast Autodilution System

Automating EPA 6020 Compliant Analysis with the Agilent 7900 ICP-MS and ESI prepfast Autodilution System Automating EPA 6020 Compliant Analysis with the Agilent 7900 ICP-MS and ESI prepfast Autodilution System Application Note Environmental Authors Austin Schultz and Jake Unnerstall, Elemental Scientific,

More information